Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences

Marco D DiBonaventura,1 Henrik Meincke,2 Agathe Le Lay,2 Janine Fournier,2 Erik Bakker,3 Allison Ehrenreich1 1Kantar Health, New York, NY, USA; 2Novo Nordisk, Copenhagen, Denmark; 3Novo Nordisk, Mexico City, Mexico Objective: The goal of this study is to investigate obesity and its concomitant effe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	DiBonaventura MD, Meincke H, Le Lay A, Fournier J, Bakker E, Ehrenreich A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	obesity quality of life costs treatment patterns weight loss Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/564d11a1c3b049388a90bcdab67b0f59
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:564d11a1c3b049388a90bcdab67b0f59
record_format	dspace
spelling	oai:doaj.org-article:564d11a1c3b049388a90bcdab67b0f592021-12-02T08:03:55ZObesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences1178-7007https://doaj.org/article/564d11a1c3b049388a90bcdab67b0f592017-12-01T00:00:00Zhttps://www.dovepress.com/obesity-in-mexico-prevalence-comorbidities-associations-with-patient-o-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Marco D DiBonaventura,1 Henrik Meincke,2 Agathe Le Lay,2 Janine Fournier,2 Erik Bakker,3 Allison Ehrenreich1 1Kantar Health, New York, NY, USA; 2Novo Nordisk, Copenhagen, Denmark; 3Novo Nordisk, Mexico City, Mexico Objective: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. Methods: Mexican adults (N=2,511) were recruited from a combination of Internet panels and street intercepts using a random-stratified sampling framework, with strata defined by age and sex, so that they represent the population. Participants responded to a survey consisting of a range of topics including sociodemographics, health history, health-related quality of life (HRQoL), work productivity, health care resource use, and weight loss. Results: The sample consisted of 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight, and 24.4% were obese. Increasing body mass index (BMI) was associated with increased rates of type 2 diabetes, prediabetes, and hypertension, poorer HRQoL, and decreased work productivity. Of the total number of respondents, 62.2% reported taking steps to lose weight with 27.6% and 17.1% having used an over-the-counter/herbal product and a prescription medication, respectively. Treatment discontinuation rates were high. Conclusion: Findings indicated that 62% of participants reported, at least, being overweight and that they were experiencing the deleterious effects associated with higher BMI despite the desire to lose weight. Given the rates of obesity, and its impact on humanistic and societal outcomes, improved education, prevention, and management could provide significant benefits. Keywords: obesity, quality of life, costs, treatment patterns, weight lossDiBonaventura MDMeincke HLe Lay AFournier JBakker EEhrenreich ADove Medical Pressarticleobesityquality of lifecoststreatment patternsweight lossSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 11, Pp 1-10 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	obesity quality of life costs treatment patterns weight loss Specialties of internal medicine RC581-951
spellingShingle	obesity quality of life costs treatment patterns weight loss Specialties of internal medicine RC581-951 DiBonaventura MD Meincke H Le Lay A Fournier J Bakker E Ehrenreich A Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
description	Marco D DiBonaventura,1 Henrik Meincke,2 Agathe Le Lay,2 Janine Fournier,2 Erik Bakker,3 Allison Ehrenreich1 1Kantar Health, New York, NY, USA; 2Novo Nordisk, Copenhagen, Denmark; 3Novo Nordisk, Mexico City, Mexico Objective: The goal of this study is to investigate obesity and its concomitant effects including the prevalence of comorbidities, its association with patient-reported outcomes and costs, and weight loss strategies in a sample of Mexican adults. Methods: Mexican adults (N=2,511) were recruited from a combination of Internet panels and street intercepts using a random-stratified sampling framework, with strata defined by age and sex, so that they represent the population. Participants responded to a survey consisting of a range of topics including sociodemographics, health history, health-related quality of life (HRQoL), work productivity, health care resource use, and weight loss. Results: The sample consisted of 50.6% male with a mean age of 40.7 years (SD=14.5); 38.3% were overweight, and 24.4% were obese. Increasing body mass index (BMI) was associated with increased rates of type 2 diabetes, prediabetes, and hypertension, poorer HRQoL, and decreased work productivity. Of the total number of respondents, 62.2% reported taking steps to lose weight with 27.6% and 17.1% having used an over-the-counter/herbal product and a prescription medication, respectively. Treatment discontinuation rates were high. Conclusion: Findings indicated that 62% of participants reported, at least, being overweight and that they were experiencing the deleterious effects associated with higher BMI despite the desire to lose weight. Given the rates of obesity, and its impact on humanistic and societal outcomes, improved education, prevention, and management could provide significant benefits. Keywords: obesity, quality of life, costs, treatment patterns, weight loss
format	article
author	DiBonaventura MD Meincke H Le Lay A Fournier J Bakker E Ehrenreich A
author_facet	DiBonaventura MD Meincke H Le Lay A Fournier J Bakker E Ehrenreich A
author_sort	DiBonaventura MD
title	Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_short	Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_full	Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_fullStr	Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_full_unstemmed	Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
title_sort	obesity in mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/564d11a1c3b049388a90bcdab67b0f59
work_keys_str_mv	AT dibonaventuramd obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT meinckeh obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT lelaya obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT fournierj obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT bakkere obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences AT ehrenreicha obesityinmexicoprevalencecomorbiditiesassociationswithpatientoutcomesandtreatmentexperiences
_version_	1718398661939953664

Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences

Ejemplares similares